vs
Side-by-side financial comparison of BGSF, INC. (BGSF) and Sanara MedTech Inc. (SMTI). Click either name above to swap in a different company.
Sanara MedTech Inc. is the larger business by last-quarter revenue ($27.5M vs $22.0M, roughly 1.2× BGSF, INC.). BGSF, INC. runs the higher net margin — -5.3% vs -5.9%, a 0.6% gap on every dollar of revenue. On growth, Sanara MedTech Inc. posted the faster year-over-year revenue change (4.6% vs -9.4%). Sanara MedTech Inc. produced more free cash flow last quarter ($3.9M vs $1.7M). Over the past eight quarters, Sanara MedTech Inc.'s revenue compounded faster (21.8% CAGR vs -5.3%).
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
Sanara MedTech Inc. is a US-based medical technology company that develops, manufactures, and distributes innovative surgical, wound care, and post-acute rehabilitation products. It mainly serves healthcare providers, hospitals, and long-term care facilities across North America, with a portfolio of FDA-cleared solutions designed to improve patient outcomes and lower clinical care operational costs.
BGSF vs SMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.0M | $27.5M |
| Net Profit | $-1.2M | $-1.6M |
| Gross Margin | 35.0% | 93.2% |
| Operating Margin | -17.6% | 23.5% |
| Net Margin | -5.3% | -5.9% |
| Revenue YoY | -9.4% | 4.6% |
| Net Profit YoY | -18.2% | 5.3% |
| EPS (diluted) | $-0.12 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.0M | $27.5M | ||
| Q3 25 | $26.9M | $26.3M | ||
| Q2 25 | $23.5M | $25.8M | ||
| Q1 25 | $20.9M | $23.4M | ||
| Q4 24 | $24.3M | $26.3M | ||
| Q3 24 | $29.8M | $21.7M | ||
| Q2 24 | $25.7M | $20.2M | ||
| Q1 24 | $24.5M | $18.5M |
| Q4 25 | $-1.2M | $-1.6M | ||
| Q3 25 | $-5.8M | $-30.4M | ||
| Q2 25 | $-3.7M | $-2.0M | ||
| Q1 25 | $-722.0K | $-3.5M | ||
| Q4 24 | $-981.0K | $-1.7M | ||
| Q3 24 | $-804.0K | $-2.9M | ||
| Q2 24 | $-761.0K | $-3.5M | ||
| Q1 24 | $-792.0K | $-1.8M |
| Q4 25 | 35.0% | 93.2% | ||
| Q3 25 | 35.9% | 92.9% | ||
| Q2 25 | 35.8% | 92.5% | ||
| Q1 25 | 36.2% | 92.2% | ||
| Q4 24 | 35.9% | 91.4% | ||
| Q3 24 | 35.9% | 90.8% | ||
| Q2 24 | 37.3% | 90.0% | ||
| Q1 24 | 38.1% | 89.8% |
| Q4 25 | -17.6% | 23.5% | ||
| Q3 25 | -3.5% | 11.2% | ||
| Q2 25 | -18.8% | -0.1% | ||
| Q1 25 | 1.6% | -8.9% | ||
| Q4 24 | -15.7% | 18.6% | ||
| Q3 24 | -3.4% | 3.6% | ||
| Q2 24 | -5.7% | -14.3% | ||
| Q1 24 | 1.7% | -8.3% |
| Q4 25 | -5.3% | -5.9% | ||
| Q3 25 | -21.6% | -115.5% | ||
| Q2 25 | -15.9% | -7.8% | ||
| Q1 25 | -3.5% | -15.1% | ||
| Q4 24 | -4.0% | -6.5% | ||
| Q3 24 | -2.7% | -13.2% | ||
| Q2 24 | -3.0% | -17.4% | ||
| Q1 24 | -3.2% | -9.5% |
| Q4 25 | $-0.12 | $-0.32 | ||
| Q3 25 | $-0.52 | $-3.40 | ||
| Q2 25 | $-0.34 | $-0.23 | ||
| Q1 25 | $-0.06 | $-0.41 | ||
| Q4 24 | — | $-0.18 | ||
| Q3 24 | $-0.07 | $-0.34 | ||
| Q2 24 | $-0.07 | $-0.41 | ||
| Q1 24 | — | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $16.6M |
| Total DebtLower is stronger | — | $46.0M |
| Stockholders' EquityBook value | $48.1M | $5.9M |
| Total Assets | $57.8M | $72.9M |
| Debt / EquityLower = less leverage | — | 7.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $16.6M | ||
| Q3 25 | $41.2M | $14.9M | ||
| Q2 25 | $2.8M | $17.0M | ||
| Q1 25 | $2.0M | $20.7M | ||
| Q4 24 | $32.0K | $15.9M | ||
| Q3 24 | $262 | $16.3M | ||
| Q2 24 | $226 | $6.2M | ||
| Q1 24 | $50 | $2.8M |
| Q4 25 | — | $46.0M | ||
| Q3 25 | — | $45.1M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $9.7M |
| Q4 25 | $48.1M | $5.9M | ||
| Q3 25 | $50.7M | $6.1M | ||
| Q2 25 | $78.3M | $35.4M | ||
| Q1 25 | $81.8M | $36.7M | ||
| Q4 24 | $82.3M | $39.4M | ||
| Q3 24 | $82.9M | $39.8M | ||
| Q2 24 | $83.2M | $41.7M | ||
| Q1 24 | $83.6M | $43.3M |
| Q4 25 | $57.8M | $72.9M | ||
| Q3 25 | $83.6M | $71.1M | ||
| Q2 25 | $149.7M | $98.8M | ||
| Q1 25 | $152.3M | $96.4M | ||
| Q4 24 | $150.1M | $88.1M | ||
| Q3 24 | $157.3K | $88.5M | ||
| Q2 24 | $159.8K | $73.4M | ||
| Q1 24 | $170.6K | $70.9M |
| Q4 25 | — | 7.74× | ||
| Q3 25 | — | 7.33× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $3.9M |
| Free Cash FlowOCF − Capex | $1.7M | $3.9M |
| FCF MarginFCF / Revenue | 7.6% | 14.0% |
| Capex IntensityCapex / Revenue | 0.1% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0K | $2.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $3.9M | ||
| Q3 25 | $-4.8M | $2.2M | ||
| Q2 25 | $2.2M | $2.7M | ||
| Q1 25 | $1.1M | $-2.0M | ||
| Q4 24 | $3.2M | $932.0K | ||
| Q3 24 | $6.5M | $2.1M | ||
| Q2 24 | $7.3M | $-1.4M | ||
| Q1 24 | $7.4M | $-1.6M |
| Q4 25 | $1.7M | $3.9M | ||
| Q3 25 | $-4.9M | $1.1M | ||
| Q2 25 | $2.1M | $902.7K | ||
| Q1 25 | $1.0M | $-3.7M | ||
| Q4 24 | $2.5M | $859.9K | ||
| Q3 24 | $6.5M | $2.0M | ||
| Q2 24 | $7.3M | $-1.5M | ||
| Q1 24 | $6.9M | $-1.7M |
| Q4 25 | 7.6% | 14.0% | ||
| Q3 25 | -18.1% | 4.2% | ||
| Q2 25 | 9.1% | 3.5% | ||
| Q1 25 | 5.0% | -15.9% | ||
| Q4 24 | 10.2% | 3.3% | ||
| Q3 24 | 21.7% | 9.4% | ||
| Q2 24 | 28.5% | -7.3% | ||
| Q1 24 | 28.1% | -9.0% |
| Q4 25 | 0.1% | 0.3% | ||
| Q3 25 | 0.4% | 4.0% | ||
| Q2 25 | 0.0% | 6.8% | ||
| Q1 25 | 0.1% | 7.4% | ||
| Q4 24 | 3.0% | 0.3% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.3% | ||
| Q1 24 | 2.0% | 0.4% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |
